Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast CancerBASELGA, José; ZAMBETTI, Milvia; CIRUELOS, Eva et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 526-534, issn 0732-183X, 9 p.Article

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2―Overexpressing Metastatic Breast CancerZHONGZHEN GUAN; BINGHE XU; LIM LEUNG, Wai et al.Journal of clinical oncology. 2013, Vol 31, Num 16, pp 1947-1953, issn 0732-183X, 7 p.Article

Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal CancerVAN CUTSEM, Eric; KÖHNE, Claus-Henning; JAE KYUNG ROH et al.The New England journal of medicine. 2009, Vol 360, Num 14, pp 1408-1417, issn 0028-4793, 10 p.Article

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal CancerBOKEMEYER, Carsten; BONDARENKO, Igor; LOOS, Anja H et al.Journal of clinical oncology. 2009, Vol 27, Num 5, pp 663-671, issn 0732-183X, 9 p.Article

Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast CancerGRADISHAR, William J; KRASNOJON, Dimitry; CHEPOROV, Sergey et al.Journal of clinical oncology. 2009, Vol 27, Num 22, pp 3611-3619, issn 0732-183X, 9 p.Article

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non―Small-Cell Lung Cancer: Final Results of a Phase III TrialSOCINSKI, Mark A; BONDARENKO, Igor; IGLESIAS, Jose L et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2055-2062, issn 0732-183X, 8 p.Article

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III StudyBERGH, Jonas; BONDARENKO, Igor M; CHAN, Arlene et al.Journal of clinical oncology. 2012, Vol 30, Num 9, pp 921-929, issn 0732-183X, 9 p.Article

Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycline Therapy: Results From a Randomized Phase III StudySPARANO, Joseph A; MAKHSON, Anatoly N; ZHUANG, Sen H et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4522-4529, issn 0732-183X, 8 p.Article